Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yet another dangling carrot from Fernandez the Flop. More vague news that did not move the needle for NXPL or OPKO, both closed in the red today.
Why didn't Mr. Lip Service Glickman announce who the "Marketing Partner" is in the PR?
Good luck trying to find out what company is marketing for Nature Made in China; nothing can be found online for any such partnership with Nature Made and a China based marketing firm.
This should be posted at top ….
S-8 out for NXPL. Initial Registration Statement for securities offered to employees pursuant to employee benefit plans.
Yea I noticed that as well. Seems shady as hell to me.
Woooo hooo best on the otc!!!!! Only 95 percent if not more are in the red……
LFG..!! RXMD>>!!!
This just gets better and better !!!! Way to go rxmd !!!!
Yep, he should step aside, let more energetic , smarter and know how to push pps up person to lead.
Must be a typo in Press Release. Should have read "weak leadership", Fernandez really has to go. After nearly two years as CEO he has done NOTHING to boost shareholders confidence, improve communication, nor increase their portfolio value. 🤣
From the PR it states in () MARKETING PARTNER.
Under " elite leadership "most of you lost 90% ? If Mars still at the helm by now you should made a lot ...
They dont want us to investigate... not a good sign.
Does the marketing partner have a name or are we supposed to figure it out ourselves?
2024 YTD prices compared to July 01, 2024, prices and market cap
NXPL Jul 01 1.07 YTD low and high 1.03 and 2.68 $21.21m June 26, 2024
OPK Jul 01 1.23 YTD low and high 0.8516 and 1.57 $0.85 B July 2024
RXMD Jul 01 1.5675 YTD low and high 0.400 and 3.50 $9.96M July 2024
THIS IS WHAT EACH AND EVERY BOARD MEMBER, FINANCIAL ADVISER AND ALL THE PEOPLE WHO ARE ADVISING NXPL , WILL HAVE TO JUSTIFY TO THE SEC; SOME OF THE LAWS ARE BROKEN, BUT SOME ACTUALLY WORK. MINORITY SHAREHOLDERS, YOU HAVE RIGHTS, USE THEM TO PROTECT YOUR INVESTMENT IN RXMD.
Thanks CM. Hopefully these channels over in China can lead to some nice sales numbers.
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner
JULY 02, 2024 8:00AM EDT
Download as PDF
New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additional E-Commerce Platforms, in Brick-and-Mortar Retail Locations and Launch In-Country Digital Marketing Programs
COCONUT GROVE, Fla., July 2, 2024 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced that it has expanded its e-commerce development program in China through a new agreement with a leading Chinese healthcare and nutritional products marketing and distribution services partner (the "Marketing Partner"). The Marketing Partner will provide NextPlat with a full range of creative content, brand marketing and product sales and distribution services and support the Company's exclusive joint e-commerce development agreement with OPKO Health Europe ("OPKO"), a subsidiary of OPKO Health, Inc. (NASDAQ: OPK).
NextPlat Corp. logo (PRNewsfoto/NextPlat Corp.)
As a marketing specialist in China, the Marketing Partner currently supports international healthcare and nutritional products companies including Nature Made and ITO, and provides logistics, warehousing and distribution services throughout China. The Marketing Partner has successfully developed and executed brand awareness campaigns for healthcare products on dozens of e-commerce sites such as Alibaba's Tmall, JD and Temu, and on digital/social platforms such as TikTok, Xiaohongshu, Weibo, Bilibili and WeChat. The Marketing Partner also supports product distribution into physical stores such as pharmacies, convenience stores and supermarkets, as well as into major U.S.-based retail chains operating in China including Costco and Sam's Club. The Marketing Partner is developing a series of digital product promotion programs for select OPKO products which are expected to contribute to NextPlat's Chinese e-commerce sales later this year. These marketing programs may include utilizing well-known Chinese social media influencers, live videos/broadcasts on social media platforms, and articles and product blogs designed to introduce OPKO products to potentially millions of consumers.
"Our unique e-commerce development program was created to provide American companies with turn-key online sales, marketing and distribution access into the large Chinese consumer market without requiring the significant international infrastructure investments typically required. Through the addition of well-established marketing specialists in China, we believe we can provide our clients with a greater array of value-added services which can help drive product awareness and revenue," said Charles M. Fernandez, Executive Chairman and CEO of NextPlat.
According to TMO Group (Health & Food Supplements, China Market, April 2024), China, with its rapidly growing middle class, shows increasing interest in lifestyle and many non-prescription health options with increases in income levels supporting an emphasis on health and wellness. The report cites data from Euromonitor International, showing that over the past five years, the health supplement market (including vitamins and dietary supplements (VDS), sports nutrition, weight management and wellbeing, and herbal/traditional supplements) in China has steadily increased, reaching approximately 387.9 billion RMB (approximately $53.3 billion) in 2023, with a compound annual growth rate of 9.6%. It is expected that by 2028, the health supplements market in China will exceed 440 billion RMB (approximately $60.5 billion). The TMO Group report also indicates that the online channel is the most important channel for VDS products, especially for cross-border imported products and that in 2023, health supplements from the U.S. and Australia were the first choices for Chinese consumers.
"Today's new healthcare products marketing partnership in China broadens our digital and physical reach, including potentially dozens of additional online platforms as well as brick-and-mortar retailers across the country. Importantly, we can offer a valuable array of digital and social media promotion capabilities provided by a partner who has built a strong client portfolio in China, allowing us to significantly enhance the marketing of our initial OPKO products," said David Phipps, President of NextPlat and CEO of Global Operations.
NextPlat's e-commerce development program, held in coordination with local Florida chambers of commerce, initially aims to help Florida-based businesses and manufacturers market and sell their products to potentially millions of new customers. The development program features NextPlat's turnkey global e-commerce solution and leverages the capabilities and reach of key partners including Alibaba and its Tmall Global platform, and additional in-country marketing and distribution specialists who support cross-border solutions enabling global brands to reach Chinese consumers.
For more information about NextPlat, please visit www.NextPlat.com and connect with us on Facebook and X.
About NextPlat Corp
NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the Company intends to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications division offering voice, data, tracking, and IoT products and services worldwide and pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc. (OTCQB: RXMD).
Forward-Looking Statements
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to launch additional e-commerce platforms, sell healthcare products in China, and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.
No Offer or Solicitation
This press release is for informational purposes only and is not intended to and shall not constitute an offer to sell or
News out!! NXPL expands E-Commerce program in China to include Broad Retail Distribution and Adds Digital/ Social Media Marketing Capabilities with New Partner
I have asked that line of questions a few times
Their focus is on florida with all the retirees.
They think there is alot of growth right in the back yard. Overhead is a big factor. Also alot of focus is on 340B. He will have added around 20 mil in revenue in the 2 years he has been here, by years end.
No vision, only BS
1000% agree with everything said/asked here
I believe part of the problem here is that we don't have a trajectory right now.
Brick and mortar pharmacies are being decimated. So are pharmcos multiple locations and dozen or so state licenses toilet paper now?
What exactly is our business model now, and is it scalable? What is the vision that Jay had which he projected to grow us to a 1 billion dollar company in 5 years?
Thanks Garrox - Very informative
Looks like the future has arrived, RXMD should benefit greatly.
CVS, Walgreens, Rite Aid closing stores: a brick and mortar downfall?
The major U.S. pharmacy chains have closed locations around the nation in recent years amid the rise in online pharmacies.
It’s a trend that Jonathan Palmer, senior health care analyst at Bloomberg Intelligence, projected will continue especially as the dependency on online services continues to grow.
Just this week, Walgreens announced that it would close a "significant" number of under performing stores across the U.S. due to ongoing challenges with profitability and declining margins.
Watch Fox Business Live
CVS HEALTH TO CLOSE HUNDREDS OF DRUGSTORES
Earlier this month, Rite Aid announced that 27 locations in Michigan and Ohio have been added to the growing number of stores it plans to close while it restructures under Chapter 11 bankruptcy.
The initial list of store closures stood at 154 and has continued to grow throughout the bankruptcy proceedings which involves footprint optimization.
In 2021, CVS announced that it was shuttering 900 of its 10,000 retail locations over a three-year period.
CVS and Walgreens declined to comment on specifics of the closures. Rite Aid has not immediately responded to FOX Business' request for comment.
Palmer told FOX Business that the closures were the result of a culmination of a couple of different things, but online pharmacies have contributed to this downfall.
RITE AID TO CLOSE 53 MORE STORES AMID BANKRUPTCY PROCEEDING
"More consumers buy online than ever before and with next-day delivery in many cases - the value proposition of retail pharmacy isn't as compelling," Palmer said.
He argued that while pharmacies are convenient for household products, they aren't cheap.
"They're at a significant premium to a Walmart or a Target," Palmer said.
On top of that, the "reimbursement for dispensing drugs has been pressured by managed care and payers for years." There have also been more alternatives than ever before, such as the likes of Amazon Pharmacy, GoodRx or Mark Cuban's Cost Plus, he noted.
While suburbia is "relatively safe" from such closures, urban and rural communities won't be. Palmer estimated that they "are likely to face the brunt of the closures."
GET FOX BUSINESS ON THE GO BY CLICKING HERE
This, he believes, should continue "as more and more options gain traction for online prescriptions."
The online channel got a significant boost in demand during the pandemic when consumers were forced to rely on it. However, the trend has persisted ever since.
"Whereas once virtual care wasn't common, suddenly online was the only option and with that adoption of virtual care there was a greater recognition that online pharmacy was also a viable route," Palmer said, adding that "everyday there are more patients who have only lived in a world where online shopping was the norm and that slow demographic shift is also a contributor."
Daniella Genovese is a consumer and business reporter for Fox Business and Fox News Digital.
This material may not be published, broadcast, rewritten, or redistributed.
©2024FOX News Network, LLC. All rights reserved.
Starting to see T-Trades on NXPL now. What scam has Fernandez begun running now?
Significant sell volume over there today, 33k shares dumped ... investors are finally seeing the light & have started to jump ship. IMO
The 2024 Shady CEO Award goes to Charles in Charge.
I have no idea, havent bought cigarettes in a few years. They do sell tall boys though 🥴
Walgreens still sells cigarettes in your state? About 4 years ago both CVS and Walgreens in NY can no longer sell tobacco products by law.
I think another factor is they're expensive. I'm not on medication, thank God, but any sort of OTC item or food item is expensive compared to a grocery store.
I personally don't shop there. Walgreens is good for cigarettes.
Locations will tell you why.
Lots of retail stores are leaving those locations as well.
Walgreens set to close numerous unprofitable locations
https://amp.cnn.com/cnn/2024/06/27/business/walgreens-closures
I’d be shocked if she agrees. She lives the life of luxury right now. Why subject herself to this job. The country is in turmoil and don’t believe our adversaries will have fear of her. But what do I know??
I have heard Michelle Obama being mentioned a lot as a replacement.
I expect nothing that will benefit us at this point…
So have you connected with Armen yet?
$20 would be around 10 cents pre split. I don’t think that’s outlandish to ask for at all.
I would say that's conservative and add maybe around 25% for the whole unit.
How I think company should be valued versus current valuation is obviously two different things.
A big problem is the only significant news announced from last two years was a reverse split. No conference calls. Barely any PRs. Market has forgotten about RXMD. You go silent on the OTC, price will reflect that.
Will things finally change after the merger? Hopefully so, but we’ll see
Speaking just for RXMD only. Not the soon to be combined entity.
Ok then why are we down here? The market sure isn’t agreeing with that sentiment.
Good morning
Is this just for Rxmd or the whole unit with nxpl ect?
You can cherry pick a number of ways to assess a company’s valuation. I like using a basic market cap of 1-2x annual revenues to serve as a baseline. At current O/S, that’d be a PPS of $10-$20.
$20 would be around 10 cents pre split. I don’t think that’s outlandish to ask for at all.
As Trackdude posted, a 9.5 million dollar market cap is an absolute joke for a company closing in on 60 million $s in revenue. The $26 million in cash sitting in the bank will eventually be put to work. A nice acquisition will do wonders.
I agree and the rest will be alot easier to watch.
While what you say is true at the moment, what do you expect to happen in the near future? I expect to see them gobble up another company.
$RXMD
How ya'll didn't see this coming is beyond me? The one year charts of both RXMD & NXPL look nearly identical because the same Mook is in charge of both companies.
The writing was on the wall, one only needed to see how he ran NXPL to determine what was going to become of RXMD. 🙊🙈🙉 See it now?
RXMD's organic growth took nearly a decade of hard work, perseverance and top-notch professionalism for Ms. Mars & Armen to achieve the $40m market cap before current CEO screwed shareholders.
It took "Fernandez the Flop" only 18 months to reduce that by 75%. Such a disgrace, this CEO needs to put his millionaire ego aside and tap out ASAP as the leader of this once thriving company.
Followers
|
745
|
Posters
|
|
Posts (Today)
|
20
|
Posts (Total)
|
195001
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |